Literature DB >> 10869367

Combinatorial chemistry and contemporary pharmacology.

J S Lazo1, P Wipf.   

Abstract

Both solid- and liquid-phase combinatorial chemistry have emerged as powerful tools for identifying pharmacologically active compounds and optimizing the biological activity of a lead compound. Complementary high-throughput in vitro assays are essential for compound evaluation. Cell-based assays that use optical endpoints permit investigation of a wide variety of functional properties of these compounds including specific intracellular biochemical pathways, protein-protein interactions, and the subcellular localization of targets. Integration of combinatorial chemistry with contemporary pharmacology now represents an important factor in drug discovery and development.

Mesh:

Substances:

Year:  2000        PMID: 10869367     DOI: 10.1002/chin.200043259

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  2 in total

1.  Combinatorial computational method gives new picomolar ligands for a known enzyme.

Authors:  Bartosz A Grzybowski; Alexey V Ishchenko; Chu-Young Kim; George Topalov; Robert Chapman; David W Christianson; George M Whitesides; Eugene I Shakhnovich
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-29       Impact factor: 11.205

Review 2.  The identification of high-affinity G protein-coupled receptor ligands from large combinatorial libraries using multicolor quantum dot-labeled cell-based screening.

Authors:  Junjie Fu; Timothy Lee; Xin Qi
Journal:  Future Med Chem       Date:  2014-05       Impact factor: 3.808

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.